Skip to main content

Want a detailed portfolio tracker?

PHXM
NASDAQ
$3.10

PHAXIAM Therapeutics SA ADR (PHXM)

PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. The company is headquartered in Lyon, France.
Website: https://www.phaxiam.com
Sector:
Healthcare
Industry:
Biotechnology

Market Cap

$20M

Price Chart

Valuation
Market Cap$20M
Profitability
EBITDA-$19M
Profit Margin-191%
Operating Margin-3232%
EPS-$13.61
Financial Health
Debt-to-Equity42.6%
Growth & Risk
Sharpe Ratio2.53